PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,947,780 | -19.8% | 5,344,446 | 0.0% | 2.07% | +13.2% |
| Q2 2023 | $8,658,003 | -23.9% | 5,344,446 | 0.0% | 1.82% | -52.3% |
| Q1 2023 | $11,383,670 | -36.8% | 5,344,446 | 0.0% | 3.82% | -44.0% |
| Q4 2022 | $18,010,783 | +346.0% | 5,344,446 | 0.0% | 6.83% | +365.6% |
| Q3 2022 | $4,038,000 | -2.8% | 5,344,446 | 0.0% | 1.47% | +6.5% |
| Q2 2022 | $4,156,000 | -12.4% | 5,344,446 | +1.9% | 1.38% | +31.3% |
| Q1 2022 | $4,747,000 | -87.8% | 5,244,446 | +10.0% | 1.05% | -86.4% |
| Q4 2021 | $38,935,000 | – | 4,765,659 | – | 7.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 748,861 | $6,815,000 | 2.37% |
| Opus Point Partners Management, LLC | 138,461 | $1,260,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,722,950 | $33,879,000 | 1.81% |
| Kerrisdale Advisers, LLC | 465,580 | $4,237,000 | 1.52% |
| DAFNA Capital Management LLC | 261,521 | $2,380,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 470,000 | $4,277,000 | 0.58% |
| Artal Group S.A. | 1,300,000 | $11,830,000 | 0.48% |
| Orbimed Advisors | 1,382,502 | $12,581,000 | 0.20% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,000 | $511,000 | 0.19% |
| ALTRINSIC GLOBAL ADVISORS LLC | 201,360 | $1,832,000 | 0.08% |